Vancouver, British Columbia--(Newsfile Corp. - June 13, 2017) - True Leaf Medicine International Ltd. (CSE: MJ) (OTC
Pink: TLFMF) (FSE: TLA) is pleased to announce that it has closed the second tranche of its recently-announced non-brokered private
placement by issuing an aggregate of 4,641,816 units (each, a "Unit") at a price of C$0.30 per Unit for aggregate gross
proceeds of C$1,392,545 (the "Private Placement"). Each Unit consists of one common share of the Company (each, a "Common
Share") and one warrant exercisable into one Common Share at a price of $0.45 for a period of 24 months. One insider of the
Company subscribed for 85,000 Units, representing C$25,500 of the gross proceeds.
In connection with the Private Placement, the Company paid an aggregate of $18,617 in cash commissions to three finders, equal
to 7% of the gross proceeds received from investors introduced to the Company by those finders.
The Company intends to use the proceeds of the Private Placement as disclosed in its news release dated May 3, 2017, and in
particular, to develop the business of its 'True Leaf Medicine', 'True Leaf Pet' and 'True Leaf Pet Europe' subsidiaries.
All securities issued pursuant to the Private Placement are subject to a statutory hold period of four month and one day.
This press release does not constitute an offer to sell or a solicitation of an offer to buy securities in the United States.
The securities referenced herein have not been and will not be registered under the United States Securities Act of 1933, as
amended (the "U.S. Securities Act"), or any state securities laws and may not be offered or sold in the United States except in
compliance with one or more exemptions from the registration requirements of the U.S. Securities Act and applicable state
securities laws.
About True Leaf:
True Leaf Medicine International Ltd., through its wholly-owned subsidiary 'True Leaf Pet', has entered the $104.9 billion
global pet care industry with a line of hemp-focused pet chews and supplements marketed through natural pet health and veterinary
channels in Canada, the United States and Europe. The Company has also filed an application under Health Canada's Access to
Cannabis for Medical Purposes Regulations (AC(MPR) to become a Canadian licensed producer through its 'True Leaf Medicine'
subsidiary. It has passed through the security screening process of Health Canada's review and is currently in the final review
stage before the 'pre-licensing inspection' approval.
For more information, please see the Company's website at www.trueleaf.com.
Investor Contact:
Kevin Bottomley
Director and Corporate Relations
kevin@trueleaf.com
M: 778-389-9933
Media Contact:
Paul Sullivan
BreakThrough Communications
p.sullivan@breakthroughpr.com
O: 604-685-4742
M: 604-603-7358
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE
ADEQUACY OR ACCURACY OF THIS PRESS RELEASE.
Forward-Looking Information:
This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate",
"expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking
statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based
are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance
that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature
they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results
could differ materially from those currently anticipated due to a number of factors and risks discussed in the Company's continuous
disclosure filings available under the Company's profile on www.sedar.com. While the Company may
elect to, it does not undertake to update this information at any particular time.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
